A drug with the SMILES C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CCC[NH+]=C(N)N)nn3)CC2)nc(N2CCN(C(=O)[C@H](C(C)C)n3cc(CCO)nn3)CC2)n1.[Cl-] has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 11.269%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CCC[NH+]=C(N)N)nn3)CC2)nc(N2CCN(C(=O)[C@H](C(C)C)n3cc(CCO)nn3)CC2)n1.[Cl-]
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CCC[NH+]=C(N)N)nn3)CC2)nc(N2CCN(C(=O)[C@H](C(C)C)n3cc(CCO)nn3)CC2)n1.[Cl-]
diaminomethylidene-[3-[1-[2-[4-[4-[4-[(2S)-2-[4-(2-hydroxyethyl)triazol-1-yl]-3-methylbutanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-2-oxoethyl]triazol-4-yl]propyl]azanium;chloride